SeelosShort with tight stop if it reaches the arrowed line and does not close above it. This line will then become the stop.
Take profit at the lower red line
Key stats
Market capitalization
83.062MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6911USD
About Seelos Therapeutics, Inc
ISIN
US81577F1093
Sector
Health Technology
Industry
Biotechnology
Website
seelostherapeutics.com
CEO
Raj Mehra
Headquarters
New York
Employees
16
Founded
1987
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Short SEEL NASDAQ:SEEL
-EMA21 cross below EMA 50
-Price breached support level 1
-Price breached support level 2
-Radar: Possible pullback or continue down, watch for price to fall below SMA200.
SEEL 519% upside according to this analyst SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.
On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to
Seelos Therapeutics Announces FDA Acceptance of Investigational SEEL: Seelos Therapeutics, Inc.
2021-11-08 08:00:00
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
SEEL BullishThe price tested the 200 sma and bounced. The current price is just bellow the POC (YTD). The divergence between the price and the MFI is a bullish signal.
Like this set up for a long swing trade. Targeting: $4.29, $6.60 in the short-midterm.
20-150% Profits Possible on SEEL Therapeutics My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15.
For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest).
Short interest in the stock is down, with most shares not available to short. This is po
SEELSEEL had an amazing day today, up 11%+! Confluence of 100% extension of AB from C and Supply make $8.50 a great target for this newly formed impulse.
Long on SEEL. View chart and like if you agreeTarget is 10 for this ascending triangle. Get ready, set...
Like if you agree
Possible Breakout Buyer seems to be present in the tape. Good consolidation to the upside. Possible runner in the next couple of days.
SEEL: Bullish Pennant (59%), Cup'n handle (92%)Primary Target:
Bullish Pennant, confirmed (59%)
PT = 6.71$
Secondary Target:
Cup'n handle, awaiting confirmation (92%)
PT = 8.26$
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0